Press release: “Citizens Against Government Waste (CAGW) released today its report Biogenerics: What They Are, Why They Are Important, and Their Economic Value to Taxpayers and Consumers. The report estimates that if the Food and Drug Administration (FDA) was provided with the appropriate statutory framework to approve generic forms of biotech drugs for the marketplace, these drugs could save taxpayers and consumers $43.2 billion between 2011 and 2020.”